Today

Agents

Chat

Arena

Discover

More

App

Enliven Therapeutics appoints Kristine Ball to board of directors - ELVN News | Rallies

Enliven Therapeutics appoints Kristine Ball to board of directors

ELVN•2026-11-05

Enliven Therapeutics appointed biopharmaceutical executive Kristine Ball to its board of directors.

1. Board appointment

Enliven Therapeutics appointed biopharmaceutical executive Kristine Ball to its board of directors.

Related News

Teradata Q3 2026 net income falls 5% to $38 million; revenue declines to $399 million

TDC•2026-11-05

Sight Sciences to present at Stifel and Piper Sandler healthcare conferences

SGHT•2026-11-05

MSC Income Fund Q3 2026 net investment income falls 13% to $14.37 million

•

2026-11-05

Guardant Health Q3 net loss widens 34% to $124.36 million as revenue rises 36% to $361 million

GH•2026-11-05

Alarum Technologies announces annual shareholder meeting

ALAR•2026-11-05